Choosing an antiseizure medicine by seizure type and patient
- Concept
The wrong antiseizure drug can make some epilepsies worse. Matching the drug to the seizure type and to the person avoids most failures.
See it in 3D: Thalamus · Temporal lobe · Hippocampus
What it is
Choosing an antiseizure medicine has two steps. First the seizure type and syndrome: narrow-spectrum drugs (carbamazepine, oxcarbazepine, phenytoin, lacosamide) control focal seizures but can worsen absence and myoclonic seizures; broad-spectrum drugs (valproate, levetiracetam, lamotrigine, topiramate) cover focal and generalized epilepsies; ethosuximide treats absences only. Second the person: the possibility of pregnancy, other medicines and enzyme induction, ancestry and HLA type, weight, mood, age and liver or kidney function. Treatment starts with one drug raised gradually; a second drug is tried alone if the first fails; epilepsy is called drug-resistant when two appropriate, tolerated drugs have failed, and then surgery or other therapies are considered.
Key points
- Monotherapy first, raised slowly to the lowest dose that controls seizures; most patients who respond do so to the first or second drug.
- Enzyme inducers (carbamazepine, phenytoin, phenobarbital) lower the levels of hormonal contraceptives, warfarin, some antiretrovirals, chemotherapy and other antiseizure drugs.
- Valproate inhibits liver enzymes and raises lamotrigine levels, raising the risk of serious rash.
- Lamotrigine needs slow titration because rash, rarely Stevens–Johnson syndrome, is more frequent with fast increases.
- Mood: levetiracetam can cause irritability and depression; lamotrigine and valproate can stabilise mood.
- Weight: valproate tends to increase weight; topiramate tends to reduce it and can cause kidney stones and word-finding difficulty.
- Phenobarbital is cheap and on the WHO essential list, useful where access is limited, but sedation and enzyme induction limit it.
How it works
- Sodium channel blockers (carbamazepine, phenytoin, lamotrigine, lacosamide) stop neurons firing rapidly and repetitively, the engine of focal seizures.
- Ethosuximide blocks T-type calcium channels in thalamic neurons, which drive the rhythmic spike-wave of absences.
- Levetiracetam binds the synaptic vesicle protein SV2A; valproate and topiramate act on several targets, which explains their broad spectrum.
Matching drug to seizure type
| Drug | Spectrum | Watch out for |
|---|---|---|
| Carbamazepine, oxcarbazepine | Focal | Worsens absence and myoclonus; enzyme induction; low sodium; HLA-related rash |
| Phenytoin | Focal and tonic-clonic | Narrow therapeutic range, enzyme induction, gum overgrowth, worsens absence |
| Lamotrigine | Broad (may worsen myoclonus in some) | Slow titration for rash; levels fall with oestrogen and in pregnancy |
| Levetiracetam | Broad | Irritability, depression; adjust in kidney failure |
| Valproate | Broad | Teratogenic, weight gain, tremor, liver toxicity, raises lamotrigine |
| Ethosuximide | Absence only | Does not protect against tonic-clonic seizures |
In practice
- A woman of 24 with juvenile myoclonic epilepsy who plans a family: levetiracetam or lamotrigine rather than valproate, with folic acid and contraception counselling.
- A man of 70 with a focal epilepsy after stroke, on warfarin: avoid enzyme inducers; lamotrigine or levetiracetam interact little.
- A patient of Han Chinese or Thai ancestry needing carbamazepine: test HLA-B*1502 first; if positive, choose another drug.
- Stopping: after a long seizure-free period (often two years or more) the drug can be tapered slowly in suitable patients; juvenile myoclonic epilepsy usually relapses.
Next step
- Classify the seizure type and syndrome (history, EEG, MRI) before choosing the drug.
- Baseline blood count, liver and kidney function, sodium before carbamazepine or oxcarbazepine; HLA-B*1502 in at-risk ancestry.
- Review all other medicines and contraception for interactions; pregnancy test and counselling in women who can become pregnant.
- Drug levels for phenytoin, suspected toxicity, poor adherence and pregnancy; not routinely for every drug.
- Refer to an epilepsy centre when two appropriate drugs have failed or the diagnosis is uncertain.
Common traps
- Any antiseizure drug works for any epilepsy: narrow-spectrum drugs can worsen absence and myoclonic seizures in generalized epilepsies.
- Adding a second drug is the next step after the first fails: switching to a different single drug is usually tried first, because side effects add up with combinations.
- Valproate is the best drug for every young woman with generalized epilepsy: its teratogenic and neurodevelopmental risks make it a last resort when pregnancy is possible.
- Normal levels mean the dose is right: the right dose is the one that controls seizures without side effects; levels help with phenytoin, adherence and pregnancy.
- After two failed drugs more drugs are the only option: drug-resistant focal epilepsy should be evaluated for surgery, which can cure it.
Test yourself
Think of the answer, then tap the question to see it.
Why can carbamazepine make a child with absence seizures worse?
Because absences come from thalamocortical spike-wave, which sodium channel blockers do not suppress and can enhance; carbamazepine is narrow spectrum, so ethosuximide or a broad-spectrum drug is chosen.
A woman on carbamazepine and a combined oral contraceptive becomes pregnant. What explains it?
Carbamazepine induces liver enzymes and speeds the breakdown of oestrogen and progestogen, so the pill fails; an intrauterine device or depot method is advised with enzyme inducers.
Lamotrigine is added to valproate and the patient develops a widespread rash. Why was the risk higher?
Valproate inhibits lamotrigine breakdown and raises its level; high levels and fast titration increase the risk of serious rash, so lamotrigine is titrated even more slowly with valproate.
A patient still has focal seizures after two well-chosen, well-tolerated drugs at adequate doses. What next?
This is drug-resistant epilepsy; a third drug rarely brings freedom from seizures, so the patient is referred to an epilepsy centre for video-EEG and assessment for surgery.
Elsewhere in DurgiPedia
- Brain rhythms and how seizures start and spread
- Valproate, carbamazepine and phenytoin
- Living with epilepsy: medication adherence, triggers, safety at home and status warning signs
Connections
See it in 3D3
The structures of Durgical's 3D anatomy where it is found.
Educational content; it does not replace supervised training, your institution's protocols or a medical assessment. It contains no doses. For signs of stroke (face drooping, arm weakness, speech trouble), a prolonged seizure or fever with a stiff neck, call the emergency number (123 in Colombia) or go to the nearest emergency department.
Sources: Treatment of epilepsy (Centers for Disease Control and Prevention, 2024); Carbamazepine: MedlinePlus Drug Information (MedlinePlus (U.S. National Library of Medicine), 2025); Lamotrigine: MedlinePlus Drug Information (MedlinePlus (U.S. National Library of Medicine), 2025); Epilepsy (fact sheet) (World Health Organization, 2024).
Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake
Representative model, for educational purposes only.
